HealthEquity, Inc (HQY) PT Raised to $77 at Chardan Capital Markets
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/12/2026
- Wall Street posts weekly gains with earnings, inflation data on tap
- Oil prices settle higher as more production shut ahead of hurricane
- Apple cuts iPhone 18 Pro orders due to soft demand, Nikkei Asia reports
- UBS flags level in gold prices where dip buyers will likely emerge
- Telecom stocks tumble on SpaceX spectrum acquisition news
- Houthi strike on Saudi airport kills 12, worst attack on kingdom in a decade
- US consumer sentiment near record low as frustration over economy mounts
- One dead in new attack on Saudi airport, a day after Houthi strike kills 13
- 8.0 Mag. Earthquake 14 Km Sw Of Pitaloza Arriba Panama - USGS
- Strong Panama quake shakes nation, but avoids major destruction
HealthEquity, Inc (HQY) PT Raised to $61 at Baird
March 20, 2018 8:20 AM EDTBaird raised its price target on HealthEquity, Inc (NASDAQ: HQY) to $61.00 (from $49.00) while maintaining a Neutral rating.
... MoreHealthEquity, Inc (HQY) PT Raised to $70 at SunTrust Robinson Humphrey
March 20, 2018 5:06 AM EDTSunTrust Robinson Humphrey raised its price target on HealthEquity, Inc (NASDAQ: HQY) to $70.00 (from $60.00) while maintaining a Buy rating.
... MoreHealthEquity, Inc (HQY) PT Raised to $66 at KeyBanc
March 20, 2018 4:21 AM EDTKeyBanc raised its price target on HealthEquity, Inc (NASDAQ: HQY) to $66.00 (from $62.00) while maintaining a Overweight rating.
... MoreHealthEquity, Inc (HQY) PT Raised to $68 at Oppenheimer
March 20, 2018 2:24 AM EDTOppenheimer raised its price target on HealthEquity, Inc (NASDAQ: HQY) to $68.00 (from $58.00) while maintaining a Outperform rating.
... MoreHealthEquity, Inc (HQY) PT Raised to $65 at Cantor Fitzgerald Following 4Q
March 20, 2018 2:20 AM EDTCantor Fitzgerald raised its price target on HealthEquity, Inc (NASDAQ: HQY) to $65.00 (from $60.00) while maintaining a Overweight rating following the company's 4Q earnings report. HQY revenue of $60.4 million, above FactSet consensus and estimates of $58 million. Adjusted EBITDA grew 44.5% as the company continues to scale.... More



